Bulk Manufacturer of Controlled Substances Application: PCI Synthesis, 53117 [2021-20762]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 183 / Friday, September 24, 2021 / Notices
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; PermitRequired Confined Spaces
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–20760 Filed 9–23–21; 8:45 am]
BILLING CODE P
Notice of availability; request
for comments.
ACTION:
DEPARTMENT OF JUSTICE
[Docket No. DEA–896]
Bulk Manufacturer of Controlled
Substances Application: PCI Synthesis
Drug Enforcement
Administration, Justice.
AGENCY:
Notice of application.
PCI Synthesis has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 23, 2021. Such
persons may also file a written request
for a hearing on the application on or
before November 23, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on March 30, 2021, PCI
Synthesis, 9 Opportunity Way,
Newburyport, Massachusetts 01950–
0195, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
Amphetamine ...............
Methamphetamine ........
I
Schedule
1100
1105
II
III
The company plans to develop
manufacturing processes, conduct
analytical method validation and
conduct bulk product stability studies.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–20762 Filed 9–23–21; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
16:50 Sep 23, 2021
The Department of Labor
(DOL) is submitting this Occupational
Safety and Health Administration
(OSHA)-sponsored information
collection request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are
invited.
DATES: The OMB will consider all
written comments that agency receives
on or before October 25, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
Comments are invited on: (1) Whether
the collection of information is
necessary for the proper performance of
the functions of the Department,
including whether the information will
have practical utility; (2) if the
information will be processed and used
in a timely manner; (3) the accuracy of
the agency’s estimates of the burden and
cost of the collection of information,
including the validity of the
methodology and assumptions used; (4)
ways to enhance the quality, utility and
clarity of the information collection; and
(5) ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
automated collection techniques or
other forms of information technology.
FOR FURTHER INFORMATION CONTACT:
Crystal Rennie by telephone at 202–
693–0456 or by email at DOL_PRA_
PUBLIC@dol.gov.
SUPPLEMENTARY INFORMATION: The
collections of information are needed by
employers and employees involved in
the entry of permit-required confined
spaces to prevent injuries and death
from exposure to the hazards associated
with such entries. For additional
substantive information about this ICR,
see the related notice published in the
Federal Register on June 23, 2021 (86
FR 32978).
This information collection is subject
to the PRA. A Federal agency generally
SUMMARY:
Drug Enforcement Administration
ACTION:
DEPARTMENT OF LABOR
Jkt 253001
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
53117
cannot conduct or sponsor a collection
of information, and the public is
generally not required to respond to an
information collection, unless the OMB
approves it and displays a currently
valid OMB Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information that does not
display a valid OMB Control Number.
See 5 CFR 1320.5(a) and 1320.6.
DOL seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
cannot be for more than three (3) years
without renewal. The DOL notes that
information collection requirements
submitted to the OMB for existing ICRs
receive a month-to-month extension
while they undergo review.
Agency: DOL–OSHA.
Title of Collection: Permit-Required
Confined Spaces.
OMB Control Number: 1218–0203.
Affected Public: Private Sector:
Businesses or other for-profits.
Total Estimated Number of
Respondents: 214,994.
Total Estimated Number of
Responses: 13,959,314.
Total Estimated Annual Time Burden:
2,076,039 hours.
Total Estimated Annual Other Costs
Burden: $645,000.
Authority: 44 U.S.C. 3507(a)(1)(D).
Crystal Rennie,
Senior PRA Analyst.
[FR Doc. 2021–20729 Filed 9–23–21; 8:45 am]
BILLING CODE 4510–26–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice: (21–061)]
Planetary Science Advisory
Committee; Meeting
National Aeronautics and
Space Administration.
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, as
amended, the National Aeronautics and
Space Administration (NASA)
announces a meeting of the Planetary
Science Advisory Committee. The
meeting will be held for the purpose of
soliciting, from the scientific
community and other persons, scientific
and technical information relevant to
program planning.
DATES: Monday, October 18, 2021, 10:00
a.m. to 6:00 p.m., Eastern Time; and
Tuesday, October 19, 2021, 10:00 a.m. to
6:00 p.m., Eastern Time
SUMMARY:
E:\FR\FM\24SEN1.SGM
24SEN1
]]>Agencies
[Federal Register Volume 86, Number 183 (Friday, September 24, 2021)]
[Notices]
[Page 53117]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20762]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-896]
Bulk Manufacturer of Controlled Substances Application: PCI
Synthesis
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: PCI Synthesis has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before November 23,
2021. Such persons may also file a written request for a hearing on the
application on or before November 23, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on March 30, 2021, PCI Synthesis, 9 Opportunity Way,
Newburyport, Massachusetts 01950-0195, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Amphetamine............................ 1100 II
Methamphetamine........................ 1105 II
------------------------------------------------------------------------
The company plans to develop manufacturing processes, conduct
analytical method validation and conduct bulk product stability
studies.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-20762 Filed 9-23-21; 8:45 am]
BILLING CODE P
